ABOUT US
Mission
History
Boards of Directors
Staff
Join PPTA
MEMBER COMPANIES
ISSUES
U.S.
Federal
State
Regulatory
European Union
Patient Access & Health Policy
Institutions
EU Member States
Other Countries
Organizations and Institutions
International
International Institutions
PLASMA & THERAPIES
Plasma & Blood
Become a Donor
Find a Donation Center
FAQ
Diseases
Therapies
PROGRAMS & STANDARDS
Donor Deferral (NDDR)
Patient Notification System
IQPP
QSEAL
Data Center
NEW! PPTA DHQ
PATIENT RESOURCES
Learn About Patients
Patient Groups
Patient Notification System
Resources
IVIG Manufacturers
PUBLICATIONS
The Source
This Season's Issue
Why Subscribe?
Subscription / Order Center
Email the Editor
Advertising Opportunities
Fact Sheets
Brochures
NEWSROOM
Calendar of Events
Press Releases
Industry Facts
Videos
Press Contacts
Subscribe to e-releases
CONTACT
PATIENT NOTIFICATION SYSTEM
Confidential notification within 24 hours of therapy withdrawals & recalls
China
USA/UK
Spain
Germany
Italy
Japan
France
Home
>
Issues
>
European Union
>
Patient Access & Health Policy
Print
Email
European Union Patient Access and Health Policy
PPTA Position Statement: EU's Role in Global Health
(December 2009)
European Parliament Call for Action - Rare Plasma Related Disorders
(June 2009)
PPTA Position Statement Regarding European Commission Call for Tender on Testing Laboratories and Testing Methods
(October 2008)
PPTA Position Statement Regarding European Commission Draft Directive on Cross-border Healthcare
(October 2008)
PPTA Position Paper: European Commission's Public Consultation on Rare Diseases: Europe's Challenges
(February 2008)
PPTA Position Paper: European Consultation on the Future of Pharmaceuticals for Human Use
(October 2007)
PPTA Position Paper: Patient Information
(June 2007)
PPTA Position Paper: The Place of Chronic, Congenital Diseases Within an EU Framework for Health Services
(December 2006)